ClearPoint Neuro Inc [NASDAQ: CLPT] gained 58.55% or 7.12 points to close at $19.28 with a heavy trading volume of 12318342 shares.
It opened the trading session at $16.2, the shares rose to $20.94 and dropped to $16.2, the range by which the price of stock traded the whole day. The daily chart for CLPT points out that the company has recorded 46.39% gains over the past six months.
If we look at the average trading volume of 417.38K shares, CLPT reached to a volume of 12318342 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about ClearPoint Neuro Inc [CLPT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLPT shares is $29.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLPT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
B. Riley Securities have made an estimate for ClearPoint Neuro Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 25, 2024. While these analysts kept the previous recommendation, Stifel raised their target price to Buy. The new note on the price target was released on October 24, 2023, representing the official price target for ClearPoint Neuro Inc stock. Previously, the target price had yet another raise to $14, while B. Riley Securities analysts kept a Buy rating on CLPT stock.
The Price to Book ratio for the last quarter was 27.76, with the Price to Cash per share for the same quarter was set at 1.46.
Trading performance analysis for CLPT stock
ClearPoint Neuro Inc [CLPT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 80.86. With this latest performance, CLPT shares gained by 83.62% in over the last four-week period, additionally plugging by 46.39% over the last 6 months – not to mention a rise of 25.36% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLPT stock in for the last two-week period is set at 87.70, with the RSI for the last a single of trading hit 1.55, and the three-weeks RSI is set at 1.01 for ClearPoint Neuro Inc [CLPT]. The present Moving Average for the last 50 days of trading for this stock 11.06, while it was recorded at 13.20 for the last single week of trading, and 13.30 for the last 200 days.
ClearPoint Neuro Inc [CLPT]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and ClearPoint Neuro Inc [CLPT] shares currently have an operating margin of -67.33% and a Gross Margin at 60.42%. ClearPoint Neuro Inc’s Net Margin is presently recorded at -66.15%.
ClearPoint Neuro Inc (CLPT) Capital Structure & Debt Analysis
According to recent financial data for ClearPoint Neuro Inc. ( CLPT), the Return on Equity (ROE) stands at -85.68%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -38.50%, reflecting the company’s efficiency in generating profits from its assets. Additionally, ClearPoint Neuro Inc’s Return on Invested Capital (ROIC) is -40.50%, showcasing its effectiveness in deploying capital for earnings.
ClearPoint Neuro Inc (CLPT) Efficiency & Liquidity Metrics
Based on ClearPoint Neuro Inc’s (CLPT) latest financial statements, the Debt-to-Equity Ratio is 1.80%, indicating its reliance on debt financing relative to shareholder equity.
ClearPoint Neuro Inc (CLPT) Efficiency & Liquidity Metrics
From an operational efficiency perspective, ClearPoint Neuro Inc. (CLPT) effectively leverages its workforce, generating an average of -$193217.39 per employee. The company’s liquidity position is robust, with a Current Ratio of 7.30% and a Quick Ratio of 6.45%, indicating strong ability to cover short-term liabilities.
ClearPoint Neuro Inc [CLPT]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, ClearPoint Neuro Inc posted -0.18/share EPS, while the average EPS was predicted by analysts to be reported at -0.17/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.01. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLPT.
An analysis of Institutional ownership at ClearPoint Neuro Inc [CLPT]
There are presently around $39.03%, or 42.51%% of CLPT stock, in the hands of institutional investors. The top three institutional holders of CLPT stocks are: VANGUARD GROUP INC with ownership of 1.22 million shares, which is approximately 4.4282%. MILLENNIUM MANAGEMENT LLC, holding 0.47 million shares of the stock with an approximate value of $$2.51 million in CLPT stocks shares; and MILLENNIUM MANAGEMENT LLC, currently with $$2.49 million in CLPT stock with ownership which is approximately 1.6841%.
